ACTIVE SUBSTANCE / INN

SALMETEROL;FLUTICASONE PROPIONATE

Brand name(s): Aerivio Spiromax, BroPair Spiromax, Seffalair Spiromax
EMA LISTED
WITHDRAWN
AUTHORISED
Asthma
Pulmonary Disease, Chronic Obstructive;Asthma
ACTIVE SUBSTANCE
Salmeterol;Fluticasone Propionate
REGULATORS
EMA
SPONSORS / MAH
Teva B.V.
TOTAL APPLICATIONS
3
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
Seffalair SpiromaxTeva B.V.Authorised26/03/2021Asthma
BroPair SpiromaxTeva B.V.Withdrawn26/03/2021Asthma
Aerivio SpiromaxTeva B.V.Withdrawn18/08/2016Pulmonary Disease, Chronic Obstructive;Asthma

FULL INTELLIGENCE ON SALMETEROL;FLUTICASONE PROPIONATE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →